Gioia U, Francia S, Cabrini M, Brambillasca S, Michelini F, Jones-Weinert CW, d'Adda di Fagagna F

Pharmacological boost of DNA damage response and repair by enhanced biogenesis of DNA damage response RNAs.

Sci Rep 2019; 6460. doi: 10.1038/s41598-019-42892-6

Pessina F, Giavazzi F, Yin Y, Gioia U, Vitelli V, Galbiati A, Barozzi S, Garre M, Oldani A, Flaus A, Cerbino R, Parazzoli D, Rothenberg E, d'Adda di Fagagna F

Functional transcription promoters at DNA double-strand breaks mediate RNA-driven phase separation of damage-response factors.

Nat Cell Biol 2019; 1286-1299. doi: 10.1038/s41556-019-0392-4

Aguado J, d'Adda di Fagagna F, Wolvetang E

Telomere transcription in ageing.

Ageing Res Rev 2020; 101115. doi: 10.1016/j.arr.2020.101115

Pessina F, Gioia U, Brandi O, Farina S, Ceccon M, Francia S, d'Adda di Fagagna F

DNA Damage Triggers a New Phase in Neurodegeneration.

Trends Genet 2021; 337-354. doi: 10.1016/j.tig.2020.09.006

Di Micco R, Krizhanovsky V, Baker D, d'Adda di Fagagna F

Cellular senescence in ageing: from mechanisms to therapeutic opportunities.

Nat Rev Mol Cell Biol 2021; 75-95. doi: 10.1038/s41580-020-00314-w

Sharma S, Anand R, Zhang X, Francia S, Michelini F, Galbiati A, Williams H, Ronato DA, Masson JY, Rothenberg E, Cejka P, d'Adda di Fagagna F

MRE11-RAD50-NBS1 Complex Is Sufficient to Promote Transcription by RNA Polymerase II at Double-Strand Breaks by Melting DNA Ends.

Cell Rep 2021; 108565. doi: 10.1016/j.celrep.2020.108565

Cabrini M, Roncador M, Galbiati A, Cipolla L, Maffia A, Iannelli F, Sabbioneda S, d'Adda di Fagagna F, Francia S

DROSHA is recruited to DNA damage sites by the MRN complex to promote non-homologous end joining.

J Cell Sci 2021; . doi: 10.1242/jcs.249706

Uryga AK, Grootaert MOJ, Garrido AM, Oc S, Foote K, Chappell J, Finigan A, Rossiello F, d'Adda di Fagagna F, Aravani D, Jorgensen HF, Bennett MR

Telomere damage promotes vascular smooth muscle cell senescence and immune cell recruitment after vessel injury.

Commun Biol 2021; 611. doi: 10.1038/s42003-021-02123-z

Chen D, Gervai JZ, Póti Á, Németh E, Szeltner Z, Szikriszt B, Gyüre Z, Zámborszky J, Ceccon M, d'Adda di Fagagna F, Szallasi Z, Richardson AL, Szüts D

BRCA1 deficiency specific base substitution mutagenesis is dependent on translesion synthesis and regulated by 53BP1.

Nat Commun 2022; 226. doi: 10.1038/s41467-021-27872-7

Rossiello F, Jurk D, Passos JF, d'Adda di Fagagna F

Telomere dysfunction in ageing and age-related diseases.

Nat Cell Biol 2022; 135-147. doi: 10.1038/s41556-022-00842-x

Falcinelli M, Dell'Omo G, Grassi E, Mariella E, Leto SM, Scardellato S, Lorenzato A, Arena S, Bertotti A, Trusolino L, Bardelli A, d'Adda di Fagagna F

Colorectal cancer patient-derived organoids and cell lines harboring ATRX and/or DAXX mutations lack Alternative Lengthening of Telomeres (ALT).

Cell Death Dis 2023; 96. doi: 10.1038/s41419-023-05640-3

Rosso I, Jones-Weinert C, Rossiello F, Cabrini M, Brambillasca S, Munoz-Sagredo L, Lavagnino Z, Martini E, Tedone E, Garre' M, Aguado J, Parazzoli D, Mione M, Shay JW, Mercurio C, d'Adda di Fagagna F

Alternative lengthening of telomeres (ALT) cells viability is dependent on C-rich telomeric RNAs.

Nat Commun 2023; 7086. doi: 10.1038/s41467-023-42831-0

Ogrodnik M, Carlos Acosta J, Adams PD, d'Adda di Fagagna F, Baker DJ, Bishop CL, Chandra T, Collado M, Gil J, Gorgoulis V, Gruber F, Hara E, Jansen-Dürr P, Jurk D, Khosla S, Kirkland JL, Krizhanovsky V, Minamino T, Niedernhofer LJ, Passos JF, Ring NAR, Redl H, Robbins PD, Rodier F, Scharffetter-Kochanek K, Sedivy JM, Sikora E, Witwer K, von Zglinicki T, Yun MH, Grillari J, Demaria M

Guidelines for minimal information on cellular senescence experimentation in vivo.

Cell 2024; 4150-4175. doi: 10.1016/j.cell.2024.05.059

Modafferi S, Farina S, Esposito F, Brandi O, Di Salvio M, Della Valle I, D'Uva S, Scarian E, Cicio G, Riccardi A, Pisati F, Garbelli A, Santini T, Pansarasa O, Morlando M, D'Ambrosi N, Cozzolino M, Cestra G, d'Adda di Fagagna F, Gioia U, Francia S

DNA damage response defects induced by the formation of TDP-43 and mutant FUS cytoplasmic inclusions and their pharmacological rescue.

Cell Death Differ 2025; 2309-2322. doi: 10.1038/s41418-025-01530-7

Sepe S, Rey F, Mancheno-Ferris A, Bigi A, Fani G, Damiani D, Cabrini M, Marinelli E, Aguado J, Contu L, di Lillo A, Boggio S, Tavella S, Rosso I, Gustincich S, Chiti F, d'Adda di Fagagna F

Telomeric DNA damage response mediates neurotoxicity of Aβ42 oligomers in Alzheimer's disease.

EMBO J 2025; 6078-6111. doi: 10.1038/s44318-025-00521-1

Esposito F, Capozzo I, Riccardi A, Gioia U, Modafferi S, Manfredi L, Colantoni A, Tavella S, Cabrini M, Iannelli F, di Lillo A, d'Adda di Fagagna F, Francia S

DROSHA, DICER, and damage-induced long ncRNA control BMI1-dependent transcriptional repression at DNA double-strand break.

Cell Rep 2025; 116605. doi: 10.1016/j.celrep.2025.116605

Terraneo F, Ceccon M, Sapkota O, Zheng T, Brizioli M, Dello Stritto A, Cummings S, Codispoti S, Ossolengo G, Orsenigo F, Magni S, Gottinger A, Mattevi A, Fuxreiter M, Fawzi NL, Lottersberger F, Giavazzi F, d'Adda di Fagagna F

The glycine-arginine-rich motif of 53BP1 modulates RNA interactions necessary for its liquid-liquid phase separation during DNA Damage Response.

bioRxiv 2026; . doi: 10.64898/2026.01.30.702603

Gallamini A, Buffa F, Bacigalupo A, Van Lint MT, Peralvo J, Pittaluga PA, Occhini D, Marmont AM

Allogeneic bone marrow transplantation in multiple myeloma.

Acta Haematol 1987; 111-4. doi: 10.1159/000205969

Fenoglio D, Li Pira G, Saverino D, Ferraris A, Lancia F, Megiovanni A, Oppezzi L, Piatti G, Buffa F, Valle MT, Kunkl A, Manca F

Handling of retroviral antigens by human antigen-presenting cells.

Res Virol 1996; 97-101. doi: 10.1016/0923-2516(96)80222-6

Manca F, Fenoglio D, Franchin E, Saverino D, Li Pira G, Buffa F, Bignardi D, Del Pup L, Palù G

Anti-HIV genetic treatment of antigen-specific human CD4 lymphocytes for adoptive immunotherapy of opportunistic infections in AIDS.

Gene Ther 1997; 1216-24. doi: 10.1038/sj.gt.3300539

Buffa FM, Fenwick JD, Nahum AE

Concerning Roberts and Hendry IJROBP 1998;41:689-699.

Int J Radiat Oncol Biol Phys 1999; 737-9.

O'Sullivan JM, McCready VR, Flux G, Norman AR, Buffa FM, Chittenden S, Guy M, Pomeroy K, Cook G, Gadd J, Treleaven J, Al-Deen A, Horwich A, Huddart RA, Dearnaley DP

High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone.

Br J Cancer 2002; 1715-20. doi: 10.1038/sj.bjc.6600348

Buffa FM, Verhaegen F, Flux GD, Dearnaley DP

A Monte-Carlo method for interface dosimetry of beta emitters.

Cancer Biother Radiopharm 2003; 463-71. doi: 10.1089/108497803322285224

Wilson GD, Saunders MI, Dische S, Daley FM, Buffa FM, Richman PI, Bentzen SM

Pre-treatment proliferation and the outcome of conventional and accelerated radiotherapy.

Eur J Cancer 2006; 363-71. doi: 10.1016/j.ejca.2005.10.022

O'Sullivan JM, Norman AR, McCready VR, Flux G, Buffa FM, Johnson B, Coffey J, Cook G, Treleaven J, Horwich A, Huddart RA, Parker CC, Dearnaley DP

A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone.

Eur J Nucl Med Mol Imaging 2006; 1055-61. doi: 10.1007/s00259-005-0010-5

Winter SC, Buffa FM, Silva P, Miller C, Valentine HR, Turley H, Shah KA, Cox GJ, Corbridge RJ, Homer JJ, Musgrove B, Slevin N, Sloan P, Price P, West CM, Harris AL

Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers.

Cancer Res 2007; 3441-9. doi: 10.1158/0008-5472.CAN-06-3322

Camps C, Buffa FM, Colella S, Moore J, Sotiriou C, Sheldon H, Harris AL, Gleadle JM, Ragoussis J

hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.

Clin Cancer Res 2008; 1340-8. doi: 10.1158/1078-0432.CCR-07-1755

%PLACEHOLDER%